Neuroaxonal Dystrophies

This is a group of rare genetic diseases that affect the brain and nerves. They cause problems with movement, learning, and behavior. The exact cause varies, but it often involves problems with the nerve cells (neurons) and their connections (axons). Different types exist, like infantile, juvenile, and adult forms.

Condition

What people with Neuroaxonal Dystrophies report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Neuroaxonal Dystrophies

What It Is

Neuroaxonal dystrophy describes damage in which the far ends of nerve fibers (axons) swell and stop working properly. The term is used both for this change, which doctors see under the microscope, and for the rare inherited diseases where it is the central feature. Because these swellings appear throughout the brain, spinal cord and peripheral nerves, the result is a gradual loss of movement, coordination, vision and, often, thinking skills. The main disease in this group is PLA2G6-associated neurodegeneration (PLAN). It forms a spectrum rather than separate illnesses. The infantile form, also called infantile neuroaxonal dystrophy or Seitelberger disease, usually begins between 6 months and 3 years of age: a child's development slows, then skills such as sitting, standing or babbling are lost. The juvenile (or atypical) form starts later in childhood, sometimes with unsteady walking, delayed speech or autistic features. The adult form usually appears in the late teens or early adulthood as dystonia (involuntary muscle tightening) and parkinsonism (slowness, stiffness, tremor and poor balance, as in Parkinson's disease), often with mood or behavior changes. The same microscopic finding can also occur with some other genetic diseases, certain vitamin deficiencies and normal aging. Those situations are different conditions, and the information below concerns the inherited PLA2G6 disease.

Causes & Risk Factors

PLAN is caused by changes (variants) in a gene called PLA2G6. This gene carries instructions for an enzyme that breaks down certain fats in cell membranes. When it does not work, nerve fibers appear to build up excess membrane material and degenerate over time. Nothing a parent did during pregnancy or a child's early life causes the disease. PLAN is inherited in an autosomal recessive pattern: a person is affected only when they inherit a non-working copy of the gene from each parent. Parents who each carry one copy are usually healthy. With each pregnancy, such a couple has a 25% chance of an affected child, a 50% chance of a child who is a healthy carrier and a 25% chance of a child who neither has the disease nor carries it. Related parents are more likely to carry the same variant. PLAN is extremely rare, estimated at about 1 to 2 per million children.

How It's Diagnosed

Diagnosis usually starts when a neurologist sees a pattern such as lost milestones, low muscle tone in the trunk, unsteady movement, crossed eyes or flickering eye movements (strabismus or nystagmus), or, in older people, dystonia and parkinsonism at an unusually young age. Brain MRI often shows shrinking of the cerebellum, the part of the brain that coordinates movement. In about half of cases, usually later in the disease, it also shows iron deposits, which is why PLAN is grouped with conditions called neurodegeneration with brain iron accumulation (NBIA). The diagnosis is confirmed with genetic testing that finds disease-causing variants in both copies of the PLA2G6 gene. If standard testing finds only one or none, a further test can look for missing or extra pieces of the gene. Tests of nerve and muscle electrical activity, brain waves and the visual pathway may support the picture. Biopsies of skin or the eye's surface membrane to look for the swollen nerve endings were used more often before genetic testing became routine. A confirmed result also lets relatives have carrier testing and lets parents consider testing in future pregnancies.

Treatment Options

There is currently no treatment that stops or reverses PLAN. Care aims to relieve symptoms, prevent complications and keep the person as comfortable and capable as possible, and it works best with a coordinated team: a neurologist, therapists, an eye specialist, nutrition and feeding specialists and, where needed, a psychiatrist. In the infantile and juvenile forms, a neurologist may prescribe anti-seizure medicines and medicines that ease muscle stiffness and dystonia. Physical and occupational therapy, positioning and bracing help limit painful shortening of muscles (contractures) and curving of the spine. Constipation is common and is treated with fiber and stool softeners, and a skin patch of scopolamine, a medicine that dries saliva, can help with drooling and excess secretions. Swallowing becomes harder over time, so changes to food texture and feeding methods, and eventually a feeding tube for some, help maintain nutrition and lower the risk of food or liquid entering the lungs (aspiration pneumonia). Developmental and educational support matters throughout. In the adult form, doctors may try dopamine-replacing medicines of the kind used for Parkinson's disease to ease slowness and stiffness. Psychiatric care addresses depression, personality change or psychosis, and early physical and occupational therapy help with balance, walking and daily tasks. Research into gene therapy and other approaches is at an early, mostly laboratory stage, and clinical trials may be an option to discuss.

What to Expect

The course depends heavily on the form. Infantile PLAN usually progresses quickly. Many children never walk or lose that ability soon after gaining it, and over time stiffness, weakness, vision loss, swallowing difficulty and cognitive decline increase. Many children with this form do not live beyond about age 10, though some live into their teens or twenties, and infections such as pneumonia are the usual cause of death. The juvenile form is often fairly stable through early childhood, then declines, typically between ages 7 and 12. Attention problems, impulsivity and emotional ups and downs are common, and life expectancy is thought to be longer than in the infantile form. The adult form tends to progress once it begins, sometimes with rapid cognitive decline. Because so few people have been described, long-term outlook for the juvenile and adult forms is uncertain. Daily life increasingly revolves around care: feeding, positioning, equipment, therapy appointments and regular checks of movement, seizures, vision, hearing, breathing and nutrition. Social support, respite help for caregivers and contact with family organizations for NBIA and neuroaxonal dystrophy can make this load more manageable.

When to Seek Help

See a doctor if a baby or young child stops gaining skills or loses ones they had, seems unusually floppy, or develops crossed or flickering eyes, or if a teenager or young adult develops unexplained stiffness, tremor, abnormal postures or a marked change in behavior. Siblings and relatives may also want genetic counseling once a family variant is known. For someone already diagnosed, contact the care team promptly about frequent coughing or choking during meals, poor feeding or weight loss, a first seizure or seizures that are becoming more frequent, or new pain from stiffness or posture. Fever, fast or labored breathing, or a new cough in someone with swallowing problems can mean aspiration pneumonia and needs same-day medical assessment.

Questions to Ask Your Doctor

  1. 1.Which form of PLAN does this look like, and what does that mean for how things may change over the next few years?
  2. 2.How should we handle feeding and swallowing to protect nutrition and lower the risk of pneumonia?
  3. 3.Which symptoms are most worth treating now, and what are the trade-offs of the medicines you suggest?
  4. 4.Should other family members have carrier testing, and what are our options for future pregnancies?
  5. 5.Are there clinical trials, specialist centers or family organizations you would recommend?

Last reviewed • Oct 2026

Educational content, not medical advice.